1-2 of 2
Grit Lorenczewski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII

Alexander Sternjak, Fei Lee, Oliver Thomas, Mercedesz Balazs, Joachim Wahl, Grit Lorenczewski, Ines Ullrich, Markus Muenz, Benno Rattel, Julie M. Bailis, Matthias Friedrich
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (5): 925–933.
https://doi.org/10.1158/1535-7163.MCT-20-0508
Published: 01 May 2021
View article titled, Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII
Open the PDF for Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII in another window
Includes: Supplementary data
Journal Articles

Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3

Patrick Baeuerle, Maria Amann, Klaus Brischwein, Petra Lutterbuese, Grit Lorenczewski, Eva Krinner, Roman Kischel, Ralf Lutterbuese, Peter Kufer, Bernd Schlereth
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C270.
Published: 01 November 2007
View article titled, Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3